Ojo, Kayode K <br/><br/>
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Oct 2008 
 - 3710-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00364-08  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Base Sequence<br/>DNA Primers--genetics<br/>DNA, Protozoan--genetics<br/>Genes, Protozoan<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Humans<br/>Models, Molecular<br/>Protein Kinase Inhibitors--pharmacology<br/>RNA Interference<br/>Recombinant Proteins--antagonists & inhibitors<br/>Species Specificity<br/>Trypanosoma brucei brucei--drug effects<br/>Trypanosomiasis, African--drug therapy